Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Antares Pharma (ATRS)

Antares Pharma (ATRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Antares Pharma 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 USA

P: 609-359-3020

Description:

Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.

Key Statistics

Overview:

Market Capitalization, $K 515,505
Shares Outstanding, K 162,620
Annual Sales, $ 63,550 K
Annual Net Income, $ -6,520 K
Last Quarter Sales, $ 23,290 K
Last Quarter Net Income, $ -5,540 K
60-Month Beta 1.03
% of Insider Shareholders 5.49%
% of Institutional Shareholders 42.98%
Float, K 153,692
% Float 94.51%

Growth:

1-Year Return 14.03%
3-Year Return 217.00%
5-Year Return 63.40%
5-Year Revenue Growth 208.20%
5-Year Earnings Growth 75.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/06/19
Earnings Per Share ttm -0.03
EPS Growth vs. Prev Qtr -175.00%
EPS Growth vs. Prev Year 25.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-5 on 01/29/99

ATRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -35.33
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -17.94
Return-on-Assets (Before Tax) -6.99
Profit Margin % -10.26
Net Margin % N/A
Debt/Equity 0.50
Price/Sales 7.93
Price/Cash Flow N/A
Price/Book 11.81
Book Value/Share 0.26
Interest Coverage -1.43
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar